Spelling suggestions: "subject:"noncytotoxic"" "subject:"nonphytotoxic""
71 |
Evaluation of a Novel Method Used to Generate CMV-Specific Cytotoxic T LymphocytesLindeman, Elizabeth A. 30 June 2015 (has links)
No description available.
|
72 |
Evaluation of the "Nickel-Ion Hypothesis" of Cytotoxic Responses in AS52 CHO Cells / The Nickel-Ion Hypothesis of Cytotoxic ResponsesFletcher, Glenn George 04 1900 (has links)
Eleven nickel compounds representing a range of solubilities and biological activities were tested for toxicity, mutagenicity, and cytosolic and nuclear nickel uptake in AS52 cells. values ranging LC50 from 2-130 ug Ni/ml for particulates and 120-150 ug Ni/ml for the water soluble salts (NiCl2, NiS04, Ni(CH3C00)2) were determined. The Ni(OH)2, NiC03 , and nickel sulphides (Ni3S2 , Ni 7S6 , amorphous NiS) exhibited similar toxicities (LC50's of 2.0, 5.8, 4.1, 8.2, 4.1 ~g Ni/ml respectively), while the nickel oxides were less toxic and showed large variations between the black, Li 2Ni 8010 , and green NiO forms (LC50's of 18.1, 75, 130 ug Ni/ml). Concentrations reducing survival to the range 20-80% were tested for mutagenicity and degree of nickel uptake. Although nickel compounds have been reported to be only weak or equivocal mutagens, the results indicate a low but significant increase in mutation rate at the gpt locus induced by all the nickel compounds tested. The majority of compounds displayed nuclear to cytoplasmic nickel ratios of ≈ 1:4 to 1:2, though this was ≈ 1:20 for nickel salts. NiC03 appeared to be intermediate in behaviour with a ratio of ≈ 1:12. Comparison of the eleven compounds at the same toxicity level (LC50) showed a 75-fold difference in exposure levels but about a 10-fold difference in cytoplasmic and nuclear nickel levels. There appears to be a very good correspondence between previously reported dissolution half times (T50's) of the compounds tested and the cytosolic nickel levels at a given toxicity level. For the water-soluble salts, previous reports have shown that cellular distribution varies from that of particulates due to differences in the manner of uptake. The present work confirms this and suggests that the compounds can be divided into three classes: watersoluble salts producing very low nuclear levels and high cytosolic levels, inert nickel oxides (green NiO and lithium nickel oxide) with relatively low nuclear and cytosolic nickel levels, and the remaining compounds (the major class) with relatively high cytosolic levels and nuclear nickel levels. Overall , the data supports the N i eke 1-Ion Hypothesis which suggests that the Ni 2+ ion is the active agent in nickel toxicity and mutagenicity, and that, as a first approximation, its intracellular concentration is responsible for the observed effects, irrespective of the nickel compound. / Thesis / Master of Science (MS)
|
73 |
A cytotoxic diterpenoid from Croton membranaceus, the major constituent of anticancer herbal formulations in GhanaBayor, M.T., Ayim, J.S.K., Marston, G., Phillips, Roger M., Shnyder, Steven, Wheelhouse, Richard T., Wright, Colin W. January 2008 (has links)
No / Croton membranaceus is used by herbalists and traditional healers in Ghana for the management of various cancers, especially prostate cancers. A methanolic extract of the roots showed cytotoxic activities against two cancer cell lines, and bioassay-guided fractionation of this extract revealed that the cytotoxic activity resided mostly in the ethyl acetate fraction. Six compounds were isolated from this fraction, including a new furano-clerodane diterpenoid (1), for which the trivial name crotomembranafuran is suggested. This compound exhibited an IC50 value of 4.1 microgram/mL (10.6 microM) against human prostate (PC-3) cells, providing some support for the traditional use of C. membranaceus in the treatment of cancers
|
74 |
A muscle mimetic polyelectrolyte–nanoclay organic–inorganic hybrid hydrogel: its self-healing, shape-memory and actuation propertiesBanerjee, S.L., Swift, Thomas, Hoskins, Richard, Rimmer, Stephen, Singha, N.K. 2019 January 1917 (has links)
Yes / Here in, we describe a non-covalent (ionic interlocking and hydrogen bonding) strategy of self-healing in a covalently crosslinked organic-inorganic hybrid 15 nanocomposite hydrogel, with special emphasize on it's improved mechanical stability. The hydrogel was prepared via in-situ free radical polymerization of sodium acrylate (SA) and successive crosslinking in the presence of poly(2-(methacryloyloxy)ethyl trimethyl ammonium chloride) (PMTAC) grafted cationically armed starch and organically modified montmorillonite (OMMT). This hydrogel shows stimuli triggered self-healing following damage in both neutral and acidic solutions (pH=7.4 and pH=1.2). This was elucidated by tensile strength and rheological analyses of the hydrogel segments joined at their fractured points. Interestingly this hydrogel can show water based shape memory effects. It was observed that the ultimate tensile strength (UTS) of the self-healed hydrogel at pH = 7.4 was comparable to extensor digitorum longus (EDL) muscle of the New Zealand white rabbit. The as synthesized self-healable hydrogel was found to be non-cytotoxic against NIH 3T3 fibroblast cells. / Medical Research Council (MRC (MR/N501888/2))
|
75 |
Defective cytotoxic T lymphocyte function in HIV infection /Kottilil, Shyamasundaran, January 1999 (has links)
Thesis (Ph.D.)--Memorial University of Newfoundland, Faculty of Medicine, 1999. / Includes bibliographical references.
|
76 |
Dissecting early mechanism of melanoma cell resistance to cytotoxic T lymphocyte attack / Etude du mécanisme précoce de la résistance des cellules du mélanome à l'attaque des lymphocytes T cytotoxiqueKhazen, Roxana 26 January 2016 (has links)
Les cellules de mélanome humain expriment différents antigènes tumoraux qui sont reconnus par les lymphocytes T cytotoxiques CD8 + (CTL) induisant des réponses spécifiques de la tumeur in vivo. Cependant, chez les patients atteints de mélanome l'efficacité de la réponse naturelle des CTL ou stimulée par thérapie est limitée. Les mécanismes sous-jacents de l'échec de la phase effectrice des CTL contre les mélanomes sont encore largement méconnus. Notre hypothèse est que l'efficacité limitée des CTL dans leur combat contre les tumeurs est le résultat d'une balance défavorable entre la capacité des CTL à tuer les tumeurs et une résistance tumorale intrinsèque à l'activité cytolytique des CTL. Au cours de ma thèse je me suis concentrée sur la dynamique moléculaire qui se produit à la synapse lytique afin de pouvoir identifier un mécanisme précoce mis en place par les cellules de mélanome face à l'attaque des CTL. En combinant l'utilisation d'approches de microscopie de pointe et des outils moléculaires, j'ai pu montrer que, lors de l'interaction avec les CTL, les cellules de mélanome humain subissent une activation de leur trafic vésiculaire endosomal et lysosomal, lequel est intensifié à la synapse lytique et corrèle avec la dégradation par la cathepsine de la perforine et un défaut de pénétration d'entrée du granzyme B. De plus, j'ai démontré que le blocage du trafic lysosomal dépendant de SNAP23, la modification du pH (intra-vésiculaire) et l'inhibition de l'activité lysosomale protéotlytique des cellules de mélanome permet de restaurer leur sensibilité à l'attaque des CTL. Nos résultats révèlent une stratégie sans précédent d' " auto-défense " des cellules de mélanome à la synapse immunologique basée sur une sécrétion lysosomale massive et sur la dégradation de la perforine sécrétée par les CTL. Ainsi pouvoir interférer avec cette stratégie synaptique d'auto-défense des cellules de mélanome pourrait contribuer à potentialiser les réponses des CTL et les immunothérapies chez les patients atteints de mélanome. / Human melanoma cells express various tumor antigens that are recognized by CD8+ cytotoxic T lymphocytes (CTL) and elicit tumor-specific responses in vivo. However, natural and therapeutically enhanced CTL responses in melanoma patients are of limited efficacy. The mechanisms underlying the failure of CTL effector phase against melanomas are still largely elusive. Our hypothesis is that the limited efficacy of CTL in their fight against tumors is the result of an unfavorable balance between CTL ability to kill tumors and an intrinsic tumor resistance to CTL cytolytic activity. During my thesis I focused on the molecular dynamics occurring at the lytic synapse in order to identify possible "early response-mechanism" of melanoma cells to CTL attack. Using a combination of cutting edge microscopy approaches and molecular tools, I showed that upon conjugation with CTL, human melanoma cells undergo an exacerbated late endosome/lysosome trafficking, which is intensified at the lytic synapse and is paralleled by cathepsin-mediated perforin degradation and deficient granzyme B penetration. Abortion of SNAP-23-dependent lysosomal trafficking, pH perturbation or impairment of lysosomal proteolytic activity restores susceptibility to CTL attack. Our results reveal an unprecedented strategy of melanoma cell "self-defense" at the immunologic synapse based on a lysosome secretory burst and perforin degradation at the lytic synapse. Interfering with this synaptic self-defense strategy might be instrumental to potentiate CTL-mediated therapies in melanoma patients.
|
77 |
Methodological aspects within the FMCA-method : do incubation time and the amount of tumor cells influence the antitumoral effect?Svensson, Johanna January 2008 (has links)
<p>ABSTRACT</p><p>Chemotherapy is a common method used for cancer treatment. Especially when it concerns cancers that have grown invasively it seems to be the only efficient treatment due to the substances ability to reach and affect almost the entire body. One major obstacle regarding chemotherapy is that the patients often develop resistance to the cytotoxic substances used. Fluorometric microculture cytotoxicity assay (FMCA) is a method developed to measure sensitivity of tumor cells to different cytotoxic substances in vitro. The assay is based on hydrolysis of fluorescein diacetate to fluorescein by cells with intact cell membranes after incubation with drugs for 72 hours. This study investigated the impact of two methodological factors that may cause errors in the achieved results; namely the possible occurrence of drug decay during incubation and the use of an inappropriate amount of cells. These factors were tested by exposing the cytotoxic drugs to pre-incubation in absence of tumor cells for different times and to use suspensions with different concentrations of cells. The results indicated occurrence of drug decay in 3 of the 18 substances tested and that the amount of cells affected the results for most of the drugs tested but to different extent.</p>
|
78 |
HIV subtype C diversity: analysis of the relationship of sequence diversity to proposed epitope locations.Ernstoff, Elana Ann January 2002 (has links)
<p>Southern Africa is facing one of the most serious HIV epidemics. This project contributes to the HIVNET, Network for Prevention Trials cohort for vaccine development. HIVÂs biology and rapid mutation rate have made vaccine design difficult. We examined HIV-1 subtype C diversity and how it relates to CTL epitope location along viral gag sequences. We found a negative correlation between codon sites under positive selection and epitope regions / suggesting epitope regions are evolutionarily conserved. It is possible that epitopes exist in non-conserved regions, yet fail to be detected due to the reference strain diverging from the circulating viral population. To test if CTL clustering is an artifact of the reference strain, we calculated differences between the gag codons and the reference strain. We found a weak negative correlation, suggesting epitopes in less conserved regions maybe evading detection. Locating conserved and optimal epitopes that can be recognized by CTLs is essential for the design of vaccine reagents.</p>
|
79 |
T-cell receptor (TCR) usage in HIV-2 infectionMoysi, Eirini January 2012 (has links)
Long-term non-progressors (LTPNs) in HIV infection target the structural protein Gag more frequently than individuals who progress to disease. However, the targeting of Gag per se does not always distinguish these two groups. Various factors have been put forth as likely explanations for this discrepancy including differences in the breadth and magnitude of observed responses, the HLA type of the host, the nature of the individual epitopes targeted and the ability of the virus to mutate these antigenic regions. The purpose of this thesis was to examine, using PBMCs isolated from HIV-2 infected LTNPs and CTL clones established in vitro, the clonotypic architecture and quality of an immunodominant HIV-2 Gag-specific response directed towards the HLA-B*3501-restricted epitope NPVPVGNIY (NY9: Gag245-253). The data presented in this thesis show that in spite of the expression of multiple inhibitory receptors on the surface of NY9-specific CD8+ T-cells, the NY9-response, which is a clonotypically 'private' response, bears a signature characterised by an increased cytotoxic sensitivity and the production of an array of cytokines, most notably IFN-γ and MIP-1β. Moreover, the results of this thesis indicate that the NY9-specific CD8+ T-cells are able to cross-recognise and lyse target B-cells pulsed with the corresponding HIV epitope PY9 and its variants at functional avidities (EC50) that are close to those exhibited by PY9-specific T-cells. However, not all mobilised TCR clonotypes are equally sensitive or equally cross-reactive. When individual CTL clones were studied it emerged that dominant clonotypes within the NY9-specific CD8+ T-cell memory pool possessed a higher avidity for tetramer and sensitivity for antigen than subdominant ones and demonstrated a better cross-reactive potential towards variants of the HIV-2 epitope. Hence, future HIV vaccine strategies may benefit from the inclusion of epitopes like NY9, the presentation of which appears to mobilise CD8+ T-cells with superior functional profiles.
|
80 |
Rôle de la leptine dans le cancer colorectal humain / Role of the leptin in colon and rectal cancer in humanAloulou, Nijez 12 November 2008 (has links)
Par sa fréquence et sa gravité, le CCR représente un réel problème de santé publique. Avec 37000 nouveaux cas par an et 15% des décès, il constitue la 2ème cause de mortalité par cancer en France. Malgré d'importants progrès thérapeutiques durant cette dernière décennie, il rest un cancer de mauvais pronostic. Des facteurs génétiques et environnementaux ont été impliqués dans la genèse de ce cancer. La caractérisation moléculaire du CCR a permis d'identifier les tumeurs par instabiblité génique, appelées MSI (Microsatelite Instability) possédant des anomalies de réparation d'appariement d'ADN (MMR mismatch repair). Celles-ci sont fréquemment retrouvées (80%) dans les CCRs familiaux et rarement (15%) dans les cancers sporadiques. Les tumeurs avec phénotype MSI sont de bon pronostic. Le rôle possible de l'alimentation et particulièrement celui du fuel énergétique sur la survenue d'anomalies d'appariement d'ADN a été suggéré. De nombreuses hormones et en particulier la leptine ont été rapportées comme facteur de promotion tumorale. De plus, la leptine possède de nombreuses propriétés immunrégulatrices. Son effet sur l'immunité colique tiendrait autant à sa capacité à initier la production de cytokines à partir des cellules épithéliales digestives qu'à sa capacité à contrôler la prolifération des lymphocytes. Nous avons formulé l'hypothèse que la leptine pouvait réguler des fonctions immunes dans le microenvironnement tumoral. L'ensemble de ces données souligne l'importance de l'étude chez l'homme. L'analyse des données prospectives de 171 patients avec CCR permet de noter une surexpression du récepteur de la leptine dans un sous groupe de tumeurs. Les relations entre le récpteur de la leptine et la réponse immunitaire ont été analysées dans le microenvironnement tumoral humain, par des modèles cellulaires in vitro et animaux in vivo. Nous avons découvert que l'effet pro immunitaire de leptine dépendait du niveau d'expression de sonrécepteur et du degré d'instabilité microsatellitaire dans la cellule tumorale. L'expression du récepteur de la leptine pourrait être considérée comme un marqueur pronostique dans le CCR humain / Cancer of the colon and rectum (CRC) is a real challenge in Western countries because of the prevalence, cost and bad prognosis. With they 37,000 new cases each year and 15% of mortality it is currently the 2nd cause of cancer death in France. Despite significant advances in diagnosis and treatment over the past decade, it remains with bad prognosis. Genetic and environmental factors were involved in the genesis of this cancer. Molecular characterization of CRC leaded to the identification of gene instability (MSI) in tumors with mismatch repair (MMR) abnormalities. This is found frequently (80%) the CRC hereditary no polyposis colon cancer family (HNPCC) and rarely (15%) in sporadic cancers. Those tumors with MSI phenotype are considered to be of good prognosis. The possible role of food and particulary energy balance on the occurrence of MMR abnormalities has been suggested. Several hormones including leptin have been reported to promote tumour growth. In addition, leptin may regulate immune response tin GIT. Its pro immunogenic effect results from cytokines production by gastrointestinal epithelial cells as well as its ability to control the proliferation of lymphocytes. We hypothesised that leptin might regulate anti tumour immune response. The analysis of prospective data from 171 patients with CRC showed that overexpression of leptin receptor in subset of tumours. Relationships between leptin recptor and tumour immune response have been studied in the tumour microenvironment in human tissues, and in culture cells in vitro as well as in animal models in vivo. Results showed intensity of immune response was depended on the level of leptin receptor expression and MSI in colon tumour cells. Thus leptin receptor expression may be considered as a prognostic marker in colon and rectal cancer in human
|
Page generated in 0.043 seconds